The global human microbiome market is projected to exhibit a significant growth, at a CAGR of around 19.5%, during the forecast period. The major factors that are primarily driving the growth of the market include the increasing emphasis on microbiome sequencing for early detection and diagnosis. Moreover, increasing government spending for promoting the microbiome research in numerous countries is expected to promote the growth of the market in the future years. Additionally, the cost associated with the sequencing technologies has decreased in the past years; this is expected to be one of the prime reasons which are expected to promote the growth of the human microbiome market during the forecast period.

Request a Free Sample of our Global Human Microbiome Market: https://www.omrglobal.com/request-sample/human-microbiome-market

In recent years, the demand for early and accurate detection of diseases is increasing rapidly. The major reason for the early detection of diseases is people are becoming more conscious about their health. A microbiome sequencing technology can be used for understanding the role of microbial components in health and disease. The sequencing of microbiome research offers a progressive method for the diagnosis and treatment of a range of chronic diseases such as cancer, irritable bowel syndrome, and diabetes, among others providing an early-detection of disease and solution. Early disease detection benefit provided by microbiome sequencing is further enhanced using AI in sequencing technology.

Human genomes consist around 20,000 genes, in comparison to human’s microbial genome which is between 2 to 20 million microbial genes making human’s genetic material 99% microbial. Gut microbes are considered the richest source of human microbes. Thus, to fully understand the human body, researchers and healthcare providers must collect data and analyze the gut microbiome. Various market players are leveraging AI in microbiome sequencing. As an instance, Viome, Inc. has developed Vie, the company’s AI system that uses data gathered from four sources including biological testing, expert knowledge, customer feedback, and scientific literature. Viome is keenly using AI tool-kits to understand and learn more about gut microbes.

A full Report of Global Human Microbiome Market is Available at: https://www.omrglobal.com/industry-reports/human-microbiome-market

Advancement in AI-based technology enables in the early and accurate diagnosis of diseases. The computer-based diagnostic tools play a major role in diagnosis and provide a platform for effective treatment of patients. The AI has the potential to expand its capabilities in medical diagnosis and through various AI applications. The technology enables in managing and increasing the demands of patients for AI tools as it is time efficient process of detecting diseases at the initial stage. This, in turn, is expected to offer growth to the human microbiome market in the near future. For instance, in 2018, Viome, Inc. has developed Vie, company’s AI system, that uses data gathered from four sources including biological testing, expert knowledge, customer feedback, and scientific literature.

Global Human Microbiome Market-Segmentation

By Product Type

• Probiotics
• Prebiotics
• Medical Foods
• Drugs
• Others (Diagnostic Tests)

By Disease

• Cancer
• Gastrointestinal Disorder
• Infectious Diseases
• Diabetes
• Others (Neurological Disorder)
By Technology

• Genomics
• Proteomics
• Metabolomics

Global Human Microbiome Market– Segment by Region

North America

• United States
• Canada
Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World

Company Profiles

• 4D pharma PLC
• BiomX Inc.
• DuPont de Nemours, Inc.
• Enterome SA
• Evelo Biosciences, Inc.
• Ferring International Center S.A.
• Illumina Inc.
• Kaleido Biosciences, Inc.
• LNC Therapeutics
• Molzym GmbH & Co. KG
• Novogene Corp.
• OptiBiotix Health PLC
• Qiagen NV
• Rebiotix Inc.
• Ritter Pharmaceuticals, Inc.
• Second Genome Inc.
• Seres Therapeutics, Inc.
• Thermo Fisher Scientific Inc.
• uBiome Inc.
• Vedanta Biosciences, Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/human-microbiome-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404